162 related articles for article (PubMed ID: 17519876)
1. The development of novel agents for the treatment of colorectal cancer: a critical review of current practice and some suggestions for the future.
Marshall JL; Gehan EA
Clin Adv Hematol Oncol; 2007 Mar; 5(3):167-72. PubMed ID: 17519876
[TBL] [Abstract][Full Text] [Related]
2. Systematic survey of therapeutic trials for metastatic colorectal cancer: room for improvement in the critical pathway.
Kopetz S; Overman M; Chang DZ; Glover KY; Shureiqi I; Wolff RA; Abbruzzese JL; Eng C
J Clin Oncol; 2008 Apr; 26(12):2000-5. PubMed ID: 18421052
[TBL] [Abstract][Full Text] [Related]
3. Oxaliplatin-based chemotherapy in the management of colorectal cancer.
Capdevila J; Elez E; Peralta S; Macarulla T; Ramos FJ; Tabernero J
Expert Rev Anticancer Ther; 2008 Aug; 8(8):1223-36. PubMed ID: 18699761
[TBL] [Abstract][Full Text] [Related]
4. Novel agents in the treatment of metastatic colorectal cancer.
Leong S; Messersmith WA; Tan AC; Eckhardt SG
Cancer J; 2010; 16(3):273-82. PubMed ID: 20526106
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenomics of colorectal cancer prevention and treatment.
Nguyen H; Tran A; Lipkin S; Fruehauf JP
Cancer Invest; 2006 Oct; 24(6):630-9. PubMed ID: 16982469
[TBL] [Abstract][Full Text] [Related]
6. Innovations in chemotherapy for metastatic colorectal cancer: an update of recent clinical trials.
O'Neil BH; Goldberg RM
Oncologist; 2008 Oct; 13(10):1074-83. PubMed ID: 18922828
[TBL] [Abstract][Full Text] [Related]
7. Integrating targeted agents into therapeutic regimens for patients with resectable colorectal cancer.
Marshall JL
Clin Colorectal Cancer; 2008 Dec; 7 Suppl 2():S63-6. PubMed ID: 19064409
[TBL] [Abstract][Full Text] [Related]
8. End points in cancer clinical trials and the drug approval process.
Schilsky RL
Clin Cancer Res; 2002 Apr; 8(4):935-8. PubMed ID: 11948095
[TBL] [Abstract][Full Text] [Related]
9. [Chemotherapy for metastatic colorectal cancer].
Iwasa S; Shimada Y
Gan To Kagaku Ryoho; 2008 Sep; 35(9):1467-74. PubMed ID: 18799899
[TBL] [Abstract][Full Text] [Related]
10. Review article: current management of metastatic colorectal cancer - the evolving impact of targeted drug therapies.
Yau T; Chan P; Ching Chan Y; Wong BC; Liang R; Epstein RJ
Aliment Pharmacol Ther; 2008 Jun; 27(11):997-1005. PubMed ID: 18363897
[TBL] [Abstract][Full Text] [Related]
11. Lessons learned from independent central review.
Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
[TBL] [Abstract][Full Text] [Related]
12. Intermittent therapy in the palliative treatment of metastatic colorectal cancer.
Wadhawan A; Stephens R; Adams R
Expert Rev Anticancer Ther; 2009 Jan; 9(1):125-34. PubMed ID: 19105712
[TBL] [Abstract][Full Text] [Related]
13. Successful gastrointestinal cancer drug development.
Hecht JR
Semin Oncol; 2006 Dec; 33(6 Suppl 11):S24-7. PubMed ID: 17178281
[TBL] [Abstract][Full Text] [Related]
14. [Biomarker for chemotherapy in patients with colorectal cancer].
Matsusaka S
Gan To Kagaku Ryoho; 2009 Jan; 36(1):11-4. PubMed ID: 19151559
[TBL] [Abstract][Full Text] [Related]
15. Molecular markers of chemotherapeutic response and toxicity in colorectal cancer.
Braun MS; Quirke P; Seymour MT
Expert Rev Anticancer Ther; 2007 Apr; 7(4):489-501. PubMed ID: 17428170
[TBL] [Abstract][Full Text] [Related]
16. From silos to a critical path of new agent development: a paradigm to revolutionize clinical research.
Benson AB
J Clin Oncol; 2008 Apr; 26(12):1924-5. PubMed ID: 18421045
[No Abstract] [Full Text] [Related]
17. The management of colorectal liver metastases: Expanding the role of hepatic resection in the age of multimodal therapy.
Chiappa A; Makuuchi M; Lygidakis NJ; Zbar AP; Chong G; Bertani E; Sitzler PJ; Biffi R; Pace U; Bianchi PP; Contino G; Misitano P; Orsi F; Travaini L; Trifirò G; Zampino MG; Fazio N; Goldhirsch A; Andreoni B
Crit Rev Oncol Hematol; 2009 Oct; 72(1):65-75. PubMed ID: 19147371
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy for patients with liver metastases from colorectal cancer.
Mandalà M; Mosconi S; Quadri A; Milesi L; Labianca R
Expert Rev Anticancer Ther; 2007 Jun; 7(6):887-97. PubMed ID: 17555399
[TBL] [Abstract][Full Text] [Related]
19. Prospects for colorectal cancer treatment: oral chemotherapy and targeted biotherapy.
Bennouna J; Douillard JY
Expert Rev Anticancer Ther; 2003 Aug; 3(4):505-17. PubMed ID: 12934662
[TBL] [Abstract][Full Text] [Related]
20. New approaches in systemic treatment of advanced colorectal cancer: the molecular targets era.
Capdevila J; Mendez G; Macarulla T; Ramos FJ; Casado E; Tabernero J
Expert Rev Anticancer Ther; 2007 Jul; 7(7):1027-41. PubMed ID: 17627462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
